SCHEMBL26259485

SCHEMBL26259485

COc1ccc2c(-n3cccc3)c(OC)cc(-n3cccc3)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.40
▸ LMNA P02545 3/20 0.40
▸ HTT P42858 3/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CA14 Q9ULX7 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ TAS1R3 Q7RTX0 1/20 0.37
▸ TAS1R1 Q7RTX1 1/20 0.37
▸ KMT2A Q03164 5/20 0.36
▸ KDM4E B2RXH2 5/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26259460 0.84 L3MBTL1 (0.40) MAPTLMNAHTTCA12CA1
SCHEMBL26259324 0.77 CYP1A2 (0.46) MAPTCA12CA1CA2CA7
SCHEMBL26259631 0.76 NQO1 (0.39) MAPTCA12CA1CA2CA7
SCHEMBL26259613 0.73 L3MBTL1 (0.37) MAPTLMNAHTTALDH1A1KMT2A
SCHEMBL28226949 0.73 CYP1A2 (0.42) LMNACA12CA1CA2CA7
SCHEMBL11039827 0.68 KDM4E (0.43) MAPTLMNACA12CA1CA2
SCHEMBL20201233 0.68 KDM4E (0.43) MAPTLMNAHTTCA12CA1
SCHEMBL13997433 0.68 HTR3E (0.51) MAPTLMNAHTTALDH1A1KMT2A
SCHEMBL30758087 0.67 ALDH1A1 (0.48) MAPTLMNACA1CA2CA7
SCHEMBL29767252 0.67 SCN2A (0.59) MAPTLMNAALDH1A1CYP3A4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 MAPT 89/4885LMNA 7/4885HTT 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback